W Health Ventures has strengthened its leadership team with the addition of four seasoned industry leaders. Ashish Singh, Dr. Prakash Patel, and Ajay Sondhi join as Operating Partners, while Mahadevan “Mahad” Narayanamoni comes on board...
Merck a global leader in science and technology is partnered with company builder mantro GmbH (Munich, Germany) to accelerate the establishment of EdiMembre, a Deep-Tech spin-out from Massachusetts, U.S.A., that is poised to disrupt the
.jpeg){kind=spacer}
AN2 Therapeutics, a company working on new drug tech, shared that it has finished the first round of doses in a test of its new drug, AN2-502998.
Two intravenous (IV) doses of the antibiotic dalbavancin spaced seven days apart are just as effective at treating complicated Staphylococcus aureus bloodstream infections as daily IV doses of conventional antibiotics given over a period of four to
Max Healthcare Institute Ltd. is set to invest Rs 6,000 crore by 2028 to significantly expand its hospital network across India, adding 3,700 new beds. This move will grow its current setup of 22 hospitals, which have around 5,000 beds, to about...
Cohance Lifesciences, a premier pharmaceutical company from India, is investing $10 million to improve cGMP bioconjugation capabilities in the United States. The investment will further strengthen the company’s position in the biologics and ADC...
Quantum computing is changing the scope of drug discovery technology, with new types of computation potentially bettering the efficiency and speed of pharmaceutical research. Drug discovery operates largely from classical simulation methods that are
Cohance Lifesciences Limited, the partner of choice for global innovative pharma companies, announces Rs. 23 crore investments and good progress on construction of its new cGMP oligonucleotide building block manufacturing facility located in
Novartis has announced positive top-line data from its Phase III NEPTUNUS-1 and NEPTUNUS-2 trials in active adult Sjögren's disease patients to assess ianalumab (VAY736) efficacy.
The international healthcare company Viatris Inc. reported that iron sucrose injection, USP, an injectable iron replacement product, has been approved by the US Food and Drug Administration (FDA) to treat iron deficiency anemia (IDA) in adult and ped
.jpg)
, CDSCO.jpg)